PS, P., F, G., EA, A., LF, C. M., A, O., MA, R. R., . . . Y, E. (2026). Radiotherapeutic management of metastatic brain disease: A two-decade meta-analysis of tumor control and neurocognitive outcomes with SRS alone versus SRS plus WBRT. Journal of neuro-oncology, 178(1), . https://doi.org/10.1007/s11060-026-05640-1
Chicago Style (17th ed.) CitationPS, Pichardo-Rojas, et al. "Radiotherapeutic Management of Metastatic Brain Disease: A Two-decade Meta-analysis of Tumor Control and Neurocognitive Outcomes with SRS Alone Versus SRS Plus WBRT." Journal of Neuro-oncology 178, no. 1 (2026). https://doi.org/10.1007/s11060-026-05640-1.
MLA (9th ed.) CitationPS, Pichardo-Rojas, et al. "Radiotherapeutic Management of Metastatic Brain Disease: A Two-decade Meta-analysis of Tumor Control and Neurocognitive Outcomes with SRS Alone Versus SRS Plus WBRT." Journal of Neuro-oncology, vol. 178, no. 1, 2026, https://doi.org/10.1007/s11060-026-05640-1.